ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $10,653,000 | -0.7% | 4,384,010 | -5.6% | 0.01% | +22.2% |
Q2 2020 | $10,728,000 | -13.9% | 4,644,310 | +2.1% | 0.01% | -25.0% |
Q1 2020 | $12,466,000 | +127.8% | 4,549,809 | -1.9% | 0.01% | +200.0% |
Q4 2019 | $5,473,000 | +88.6% | 4,638,310 | +69.4% | 0.00% | +100.0% |
Q3 2019 | $2,902,000 | +4.0% | 2,738,200 | +51.1% | 0.00% | 0.0% |
Q2 2019 | $2,791,000 | -39.5% | 1,812,200 | +56.4% | 0.00% | -50.0% |
Q1 2019 | $4,611,000 | +378.3% | 1,158,600 | +217.4% | 0.00% | +300.0% |
Q4 2018 | $964,000 | -63.2% | 365,000 | +23.2% | 0.00% | 0.0% |
Q2 2018 | $2,620,000 | +18.7% | 296,300 | +24.9% | 0.00% | -50.0% |
Q1 2018 | $2,207,000 | -6.2% | 237,300 | -24.4% | 0.00% | -33.3% |
Q4 2017 | $2,354,000 | -48.7% | 313,800 | -27.2% | 0.00% | -40.0% |
Q3 2017 | $4,589,000 | +58.7% | 430,900 | +69.8% | 0.01% | +25.0% |
Q2 2017 | $2,892,000 | +47.9% | 253,700 | +39.5% | 0.00% | +33.3% |
Q1 2017 | $1,955,000 | +711.2% | 181,900 | +762.1% | 0.00% | – |
Q4 2016 | $241,000 | -75.3% | 21,100 | -39.0% | 0.00% | -100.0% |
Q4 2015 | $974,000 | – | 34,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 5,118,560 | $14,025,000 | 1.27% |
Ikarian Capital, LLC | 3,638,000 | $9,968,000 | 0.75% |
Rubric Capital Management LP | 871,100 | $2,387,000 | 0.38% |
Burrage Capital Management LLC | 135,898 | $363,000 | 0.36% |
Soleus Capital Management, L.P. | 81,200 | $222,000 | 0.26% |
Artal Group S.A. | 1,000,000 | $2,740,000 | 0.12% |
BOOTHBAY FUND MANAGEMENT, LLC | 497,857 | $1,364,000 | 0.11% |
Alambic Investment Management, L.P. | 10,700 | $29,000 | 0.07% |
LORD, ABBETT & CO. LLC | 1,688,490 | $4,627,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 530,952 | $1,455,000 | 0.02% |